WonderTx targets 'left behind' chemistry molecules with AI drug discovery
ycombinator · x · 2026-08-25
Startup WonderTx is building an AI drug discovery platform designed to go beyond the common targets and molecules currently studied. The company aims to create medicines that would not otherwise exist, focusing on targets that traditional chemistry has left behind.
More from Venture
- 10 revenue-driving Grok Bot workflows: outreach, ads, clipping, running 24/7 — EXM7777 · 2026-08-25
- PromptQL founder shares 6 lessons from closing a $10M+ AI deal at a Fortune 500 — prasanna_says · 2026-08-25
- Relace cuts Deepseek v3 inference costs by nearly 50% on OpenRouter — stuffyokodraws · 2026-08-25
- Hugging Face Annualized Revenue Jumps 50% to Over $150M in Two Months — rohanpaul_ai · 2026-08-25
- Nvidia-Backed AI Cloud Lambda in Talks to Raise $3B — SumitGup · 2026-08-25
- Dev case: Building a Grok bot with Cursor earned $999 profit in 24 hours — jeff_weinstein · 2026-08-25